Financials GL Sciences Inc.

Equities

7705

JP3385850007

Office Equipment

Market Closed - Japan Exchange 02:00:00 2024-07-11 am EDT 5-day change 1st Jan Change
2,859 JPY +0.14% Intraday chart for GL Sciences Inc. +0.35% +13.27%

Valuation

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024
Capitalization 1 15,975 10,106 25,568 26,009 23,669 28,235
Enterprise Value (EV) 1 13,045 7,065 23,772 23,849 24,099 27,491
P/E ratio 7.96 x 6.19 x 11.3 x 9.31 x 6.76 x 8.23 x
Yield 1.93% 3.05% 1.4% 1.78% 2.6% -
Capitalization / Revenue 0.64 x 0.4 x 0.88 x 0.79 x 0.61 x 0.76 x
EV / Revenue 0.53 x 0.28 x 0.81 x 0.72 x 0.62 x 0.74 x
EV / EBITDA 3.35 x 1.85 x 4.75 x 3.98 x 3.16 x 3.69 x
EV / FCF 75 x 12.1 x -21.6 x 89.7 x -13.5 x 25 x
FCF Yield 1.33% 8.28% -4.62% 1.12% -7.41% 4%
Price to Book 0.78 x 0.47 x 1.07 x 0.97 x 0.79 x 0.84 x
Nbr of stocks (in thousands) 10,260 10,260 10,260 10,260 10,260 10,260
Reference price 2 1,557 985.0 2,492 2,535 2,307 2,752
Announcement Date 6/28/19 6/26/20 6/25/21 6/24/22 6/23/23 6/26/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024
Net sales 1 24,800 25,530 29,217 33,119 38,679 37,148
EBITDA 1 3,891 3,816 5,005 5,994 7,622 7,442
EBIT 1 2,989 2,716 3,847 4,807 6,034 5,714
Operating Margin 12.05% 10.64% 13.17% 14.51% 15.6% 15.38%
Earnings before Tax (EBT) 1 3,422 2,761 3,963 4,998 6,490 6,245
Net income 1 2,006 1,633 2,257 2,795 3,499 3,430
Net margin 8.09% 6.4% 7.72% 8.44% 9.05% 9.23%
EPS 2 195.5 159.2 220.0 272.4 341.0 334.3
Free Cash Flow 1 174 584.8 -1,099 266 -1,786 1,101
FCF margin 0.7% 2.29% -3.76% 0.8% -4.62% 2.96%
FCF Conversion (EBITDA) 4.47% 15.32% - 4.44% - 14.79%
FCF Conversion (Net income) 8.67% 35.81% - 9.52% - 32.09%
Dividend per Share 2 30.00 30.00 35.00 45.00 60.00 -
Announcement Date 6/28/19 6/26/20 6/25/21 6/24/22 6/23/23 6/26/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: Marzo 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 13,210 15,075 8,479 8,514 17,851 9,825 8,181 17,135 9,179
EBITDA - - - - - - - - -
EBIT 1 1,735 2,150 1,260 1,264 2,734 1,603 1,079 2,536 1,495
Operating Margin 13.13% 14.26% 14.86% 14.85% 15.32% 16.32% 13.19% 14.8% 16.29%
Earnings before Tax (EBT) 1 1,940 2,154 1,339 1,509 3,118 1,605 1,367 2,881 1,512
Net income 1 1,026 1,113 713 750 1,526 845 672 1,496 792
Net margin 7.77% 7.38% 8.41% 8.81% 8.55% 8.6% 8.21% 8.73% 8.63%
EPS 2 100.0 108.5 69.49 73.12 148.8 82.34 65.56 145.8 77.24
Dividend per Share - - - - - - - - -
Announcement Date 11/2/20 11/2/21 2/3/22 8/3/22 11/8/22 2/7/23 8/3/23 11/6/23 2/9/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024
Net Debt 1 - - - - 430 -
Net Cash position 1 2,930 3,041 1,796 2,160 - 744
Leverage (Debt/EBITDA) - - - - 0.0564 x -
Free Cash Flow 1 174 585 -1,099 266 -1,786 1,101
ROE (net income / shareholders' equity) 10.7% 8.19% 10.7% 12% 13.4% 11.5%
ROA (Net income/ Total Assets) 6.06% 5.21% 6.7% 7.36% 8.03% 6.7%
Assets 1 33,121 31,348 33,688 37,984 43,601 51,182
Book Value Per Share 2 1,990 2,085 2,328 2,612 2,913 3,279
Cash Flow per Share 2 528.0 574.0 620.0 596.0 639.0 726.0
Capex 1 1,968 1,341 3,305 2,751 3,100 1,458
Capex / Sales 7.94% 5.25% 11.31% 8.31% 8.01% 3.92%
Announcement Date 6/28/19 6/26/20 6/25/21 6/24/22 6/23/23 6/26/24
1JPY in Million2JPY
Estimates
  1. Stock Market
  2. Equities
  3. 7705 Stock
  4. Financials GL Sciences Inc.